Abstract:OBJECTIVE:To transplant intravenously human brain-derived neurotrophic factor (hBDNF) gene-modified bone marrow mesenchymal stem cells (BMSCs) marked with enhanced green fluorescent protein (EGFP) to injured spinal cord of adult rats, then to observe the viability of the cells and the expressions of the gene in spinal cord, as well as the influence of neurological morphological repairing and functional reconstruction.METHODS:Ninety-six male SD rats weighing (250 +/- 20) g were randomly divided into 4 groups: hBDNF-EGFP-BMSCs transplantation group (group A, n = 24), Ad5-EGFP-BMSCs transplantation group (group B, n = 24), control group (group C, n = 24), and sham operation group (group D, n = 24). In groups A, B, and C, the spinal cord injury models were prepared according to the modified Allen method at the level of T10 segment, and after 3 days, 1 mL hBDNF-EGFP-BMSCs suspension, 1 mL Ad5-EGFP-BMSCs suspension and 1 mL 0.1 mol/L phosphate buffered saline (PBS) were injected into tail vein, respectively; in group D, the spinal cord was exposed without injury and injection. At 24 hours after injury and 1, 3, 5 weeks after intravenous transplantation, the structure and neurological function of rats were evaluated by the Basso-Beattie-Bresnahan (BBB) score, cortical somatosensory evoked potential (CSEP) and transmission electron microscope. The viability and distribution of BMSCs in the spinal cord were observed by fluorescent inverted phase contrast microscope and the level of hBDNF protein expression in the spinal cord was observed and analyzed with Western blot. Meanwhile, the expressions of neurofilament 200 (NF-200) and synaptophysin I was analyzed with immunohi stochemistry.RESULTS:After intravenous transplantation, the neurological function was significantly improved in group A. The BBB scores and CSEP in group A were significantly higher than those in groups B and C (P < 0.05) at 3 and 5 weeks. The green fluorescence expressions were observed at the site of injured spinal cord in groups A and B at 1, 3, and 5 weeks. The hBDNF protein expression was detected after 1, 3, and 5 weeks of intravenous transplantation in group A, while it could not be detected in groups B, C, and D by Western blot. The expressions of NF-200 and synaptophysin I were stronger and stronger with transplanting time in groups A, B, and C. The expressions of NF-200 and synaptophysin I were strongest at 5 weeks, and the expressions in group A were stronger than those in groups B and C (P < 0.05). And the expressions of NF-200 in groups A, B, and C were significantly stronger than those in group D (P < 0.05), whereas the expressions of synaptophysin I in groups A, B, and C were significantly weaker than those in group D (P < 0.05). Ultramicrostructure of spinal cords in group A was almost normal.CONCLUSION:Transplanted hBDNF-EGFP-BMSCs can survive and assemble at the injured area of spinal cord, and express hBDNF. Intravenous implantation of hBDNF-EGFP-BMSCs could promote the restoration of injured spinal cord and improve neurological functions.

Neuroprotetive effect of glial cell line-derived neurotrophic factor gene-modified bone marrow stromal cells transplantation on intracerebral hemorrhage in rats

Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia

Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation.

Brain-derived Neurotrophic Factor Combined with Neural Stem Cells Transplantation in Treatment of Severe Traumatic Brain Injury in Rats

Neuroprotective Effect Of Grafting Gdnf Gene-Modified Neural Stem Cells On Cerebral Ischemia In Rats

Transplantation of Hypoxia Preconditioned Bone Marrow Mesenchymal Stem Cells Enhances Angiogenesis and Neurogenesis after Cerebral Ischemia in Rats.

Effect of Bone Marrow Stromal Cell Transplantation on Neurologic Function and Expression of VEGF in Rats with Focal Cerebral Ischemia

Growth-Associated Protein 43 and Neural Cell Adhesion Molecule Expression Following Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in A Rat Model of Ischemic Brain Injury

Effect of expression of growth associated protein-43(GAP-43) and BMSCs transplantion after cerebral ischemia injury* in cerebral nerve repairing

Effect of Neural Stem Cell Transplantation Pretreated with Brain-derived Neurotrophic Factor on Acute Isch-emic Stroke in Mice

Upregulated Gene Expression of Local Brain-Derived Neurotrophic Factor and Nerve Growth Factor after Intracisternal Administration of Marrow Stromal Cells in Rats with Traumatic Brain Injury

Effect of neural stem cell transplantation on neurological function of cerebral hemorrhage rats

Effect of free NgR-modified bone marrow stromal cell transplantation on axon regeneration after spinal cord injury

The Grafting Neural Stem Cells Modified by GDNF Gene Enhances the Expression of GAP-43 in Rats Subjected to Cerebral Ischemia Reperfusion

Expression of Cytokines in Rat Brain with Focal Cerebral Ischemia after Grafting with Bone Marrow Stromal Cells and Endothelial Progenitor Cells

[Preliminary Study on Effects of Human Brain-Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells by Intravenous Transplantation on Structure and Function of Rat Injured Spinal Cord].

Marrow Stem Cells Transplantation and Its Correlation with Expression of Growth Associated Protein-43 in Rats with Cerebral Ischemia Injury

Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke

Effects of Human Bone Marrow Stromal Cells Intracerebral Transplantation on the Improvement of Hypoxic-Ischemic Brain Damage in Rats

Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury

Neuroprotective Effects of Intravenous Transplantation of Bone Marrow Mononuclear Cells from 5-Fluorouracil Pre-Treated Rats on Ischemic Stroke